Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Prostatic Neoplasms 13Glioblastoma 7Breast Neoplasms 7Brain Neoplasms 7Astrocytoma 7Oligodendroglioma 6Glioma 6Neoplasms 5Gliosarcoma 5Ependymoma 5Thyroid Neoplasms 4Meningioma 4Medulloblastoma 4Lung Neoplasms 4Esophageal Neoplasms 4Uterine Cervical Neoplasms 3Thyroid Cancer, Papillary 3Rectal Neoplasms 3Pancreatic Neoplasms 3Neuroectodermal Tumors, Primitive 3Lymphoma 3Hodgkin Disease 3Glioma, Subependymal 3Colorectal Neoplasms 3Colonic Neoplasms 3Adenocarcinoma, Follicular 3Waldenstrom Macroglobulinemia 2Pinealoma 2Optic Nerve Glioma 2Neuroblastoma 2

Interventions

Cisplatin 161Fluorouracil 135Paclitaxel 127Radiotherapy 125Oxaliplatin 88Carboplatin 72Docetaxel 71Irinotecan 60pembrolizumab 57Leucovorin 57Capecitabine 57Radiation 48Esophagectomy 44Surgical Procedures, Operative 42Drug Therapy 38Neoadjuvant Therapy 28Cetuximab 25Nivolumab 24Bevacizumab 21camrelizumab 20Trastuzumab 20S 1 (combination) 19Chemoradiotherapy 19Magnetic Resonance Spectroscopy 18Epirubicin 16Albumin-Bound Paclitaxel 16Blood Specimen Collection 15tislelizumab 14Taxes 14Radiotherapy, Intensity-Modulated 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Esophageal Neoplasms × 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole × Clear all
NCT02213497 2026-01-08

Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer

Abramson Cancer Center at Penn Medicine

Phase 1 Active not recruiting
30 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02139488 2019-06-27

Organ Motion and Early Tumor Response Measurement

The Netherlands Cancer Institute

Completed
80 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01561014 2018-07-02

Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Wake Forest University Health Sciences

Phase 1 Completed
9 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT01129206 2016-06-01

Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
6 enrolled 6 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡